Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenoMar Genetics Group is an aquaculture breeding company founded in 1996 in Oslo, Norway, specializing in genetically improved tilapia strains for sustainable farming. Acquired by EW GROUP, the company develops superior tilapia genetics through genomic selection and operates breeding centers in the Philippines and Brazil, along with production facilities in Vietnam. It supplies markets in Asia and Latin America with key brands like GenoMar Supreme Tilapia (GST) and GenoMar Strong, selected for superior growth, disease resistance, and fillet yield.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenoMar Genetics Group.